Beyond The Numbers: 14 Analysts Discuss Progyny Stock
Portfolio Pulse from Benzinga Insights
Progyny (NASDAQ:PGNY) has been analyzed by 14 analysts, showing a range of opinions from bullish to bearish. The average 12-month price target has decreased by 19.15% to $27.86. Analysts have adjusted their ratings and price targets, reflecting changing market conditions and company performance. Progyny's financial metrics show strong net margin, ROE, and ROA, but its revenue growth lags behind industry peers.
September 20, 2024 | 7:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Progyny's stock has been subject to mixed analyst ratings, with a notable decrease in the average price target by 19.15%. Despite strong financial metrics like net margin and ROE, the company's revenue growth is below industry averages, which may influence investor sentiment.
The decrease in the average price target by 19.15% suggests a more cautious outlook from analysts, which could lead to neutral short-term price movement. However, strong financial metrics like net margin and ROE provide a positive counterbalance. The mixed analyst ratings and adjustments in price targets reflect a cautious market sentiment, but the company's strong financial health may mitigate negative impacts.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100